Introduction
The BioGENEius Challenge is the flagship program of the Biotechnology Institute, an educational non-profit 501(c)3 serving students in grades 3-12.
The Biotechnology Institute aims to engage, excite, and educate as many people as possible about biotechnology. It educates young students about biotechnology's immense potential in healthcare, the economy, and environmental balance. It promotes excellence in biotechnology research from the best and brightest minds in the next generation of innovators. Its efforts unite the national biotechnology community, including students, teachers, schools, and mentors, in delivering more effective workforce development and training to sustain the industry's growth and impact.
The BioGENEius Challenge provides high school-age students with an opportunity to compete and be recognized for outstanding research in biotechnology. Drawn from state and regional science competitions across the U.S. and through State Partners, the very top 2024 finalists showcased their research before judges comprised of industry and academic subject matter experts. The 2024 BioGENEius Challenge occurred during the 2024 BioFuture Conference, held from October 28-30, 2024 at CURE, which sponsored the 2024 BioGENEius Challenge.
The 2024 BioGENEius Challenge judges included:
Jeremy Abbate, Publisher, Scientifc American
Patrik Frei, CEO, Venture Valuation
Walter Greenleaf, PhD, Neuroscientist and Product Developer, Stanford University
Seema Kumar, CEO of Cure
Andrew W. Lam, PharmD, Managing Director, Head of Biotech Private Equity, Ally Bridge Group
Susanna Ling, Senior Vice President, Programs, Partnerships, Sponsorships, Cure
Viq Pervaaz, Senior Vice President, Life Sciences and Healthcare, New York City Economic Development Corporation.
Learn more at https://biotechinstitute.org/biogeneius/.
